Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Pancreatitis-diabetes-pancreatic cancer: summary of an NIDDK-NCI workshop.

Andersen DK, Andren-Sandberg Å, Duell EJ, Goggins M, Korc M, Petersen GM, Smith JP, Whitcomb DC.

Pancreas. 2013 Nov;42(8):1227-37. doi: 10.1097/MPA.0b013e3182a9ad9d.

2.

Comment on Andersen et al, pancreatitis-diabetes-pancreatic cancer: summary of an NIDDK-NCI workshop.

Moses AC, Knudsen LB, Svendsen CB.

Pancreas. 2014 May;43(4):657. doi: 10.1097/MPA.0000000000000037. No abstract available.

3.
4.

Analysis of global gene expression profiles suggests a role of acute inflammation in type 3C diabetes mellitus caused by pancreatic ductal adenocarcinoma.

Gao W, Zhou Y, Li Q, Zhou Q, Tan L, Song Y, Zhao X, Yu M, Zheng S, Ye H, Zeng B, Lin Q, Zhou J, Liu Y, Huang H, Zhang H, Hu X, Li Z, Dai X, Chen R.

Diabetologia. 2015 Apr;58(4):835-44. doi: 10.1007/s00125-014-3481-8. Epub 2015 Jan 31.

PMID:
25636208
5.

Ras activity in acinar cells links chronic pancreatitis and pancreatic cancer.

Logsdon CD, Ji B.

Clin Gastroenterol Hepatol. 2009 Nov;7(11 Suppl):S40-3. doi: 10.1016/j.cgh.2009.07.040. Review.

6.

Association of diabetes mellitus and pancreatic adenocarcinoma: a meta-analysis of 88 studies.

Batabyal P, Vander Hoorn S, Christophi C, Nikfarjam M.

Ann Surg Oncol. 2014 Jul;21(7):2453-62. doi: 10.1245/s10434-014-3625-6. Epub 2014 Mar 9.

PMID:
24609291
7.

Chronic pancreatitis: a path to pancreatic cancer.

Pinho AV, Chantrill L, Rooman I.

Cancer Lett. 2014 Apr 10;345(2):203-9. doi: 10.1016/j.canlet.2013.08.015. Epub 2013 Aug 24. Review.

PMID:
23981573
8.

The role of inflammation in pancreatic cancer.

Hausmann S, Kong B, Michalski C, Erkan M, Friess H.

Adv Exp Med Biol. 2014;816:129-51. doi: 10.1007/978-3-0348-0837-8_6. Review.

PMID:
24818722
9.

The relationship between new-onset diabetes mellitus and pancreatic cancer risk: a case-control study.

Ben Q, Cai Q, Li Z, Yuan Y, Ning X, Deng S, Wang K.

Eur J Cancer. 2011 Jan;47(2):248-54. doi: 10.1016/j.ejca.2010.07.010. Epub 2010 Aug 13.

PMID:
20709528
10.

Pancreatic fatty degeneration and fibrosis as predisposing factors for the development of pancreatic ductal adenocarcinoma.

Tomita Y, Azuma K, Nonaka Y, Kamada Y, Tomoeda M, Kishida M, Tanemura M, Miyoshi E.

Pancreas. 2014 Oct;43(7):1032-41. doi: 10.1097/MPA.0000000000000159.

PMID:
24991971
11.

Impact of diabetes mellitus on perioperative outcomes after resection for pancreatic adenocarcinoma.

Chu CK, Mazo AE, Sarmiento JM, Staley CA, Adsay NV, Umpierrez GE, Kooby DA.

J Am Coll Surg. 2010 Apr;210(4):463-73. doi: 10.1016/j.jamcollsurg.2009.12.029.

PMID:
20347739
12.

Glucagon/insulin ratio as a potential biomarker for pancreatic cancer in patients with new-onset diabetes mellitus.

Kolb A, Rieder S, Born D, Giese NA, Giese T, Rudofsky G, Werner J, Büchler MW, Friess H, Esposito I, Kleeff J.

Cancer Biol Ther. 2009 Aug;8(16):1527-33. Epub 2009 Aug 13.

PMID:
19571666
13.

Total pancreatectomy with islet autotransplantation: summary of a National Institute of Diabetes and Digestive and Kidney diseases workshop.

Bellin MD, Gelrud A, Arreaza-Rubin G, Dunn TB, Humar A, Morgan KA, Naziruddin B, Rastellini C, Rickels MR, Schwarzenberg SJ, Andersen DK.

Pancreas. 2014 Nov;43(8):1163-71. doi: 10.1097/MPA.0000000000000236.

14.

Identification of genetic risk for pancreatic adenocarcinoma.

Flores K, Dinh K, Rouleau E, Whalen G, Wassef W, LaFemina J.

Cancer Genet. 2015 Nov;208(11):559-63. doi: 10.1016/j.cancergen.2015.09.002. Epub 2015 Sep 24.

PMID:
26481832
15.

Comparative characterization of stroma cells and ductal epithelium in chronic pancreatitis and pancreatic ductal adenocarcinoma.

Helm O, Mennrich R, Petrick D, Goebel L, Freitag-Wolf S, Röder C, Kalthoff H, Röcken C, Sipos B, Kabelitz D, Schäfer H, Oberg HH, Wesch D, Sebens S.

PLoS One. 2014 May 5;9(5):e94357. doi: 10.1371/journal.pone.0094357. eCollection 2014.

16.

Malignancy in chronic pancreatitis: analysis of diagnostic procedures and proposal of a clinical algorithm.

Rückert F, Brussig T, Kuhn M, Kersting S, Bunk A, Hunger M, Saeger HD, Niedergethmann M, Post S, Grützmann R.

Pancreatology. 2013 May-Jun;13(3):243-9. doi: 10.1016/j.pan.2013.03.014. Epub 2013 Apr 6.

PMID:
23719595
17.

Presence of pancreatic intraepithelial neoplasia-3 in a background of chronic pancreatitis in pancreatic cancer patients.

Hwang IK, Kim H, Lee YS, Kim J, Cho JY, Yoon YS, Han HS, Hwang JH.

Cancer Sci. 2015 Oct;106(10):1408-13. doi: 10.1111/cas.12744. Epub 2015 Sep 4.

18.

Prevention of pancreatic cancer by the beta-blocker propranolol.

Al-Wadei HA, Al-Wadei MH, Schuller HM.

Anticancer Drugs. 2009 Jul;20(6):477-82. doi: 10.1097/CAD.0b013e32832bd1e3.

19.

Global microRNA expression profiling of microdissected tissues identifies miR-135b as a novel biomarker for pancreatic ductal adenocarcinoma.

Munding JB, Adai AT, Maghnouj A, Urbanik A, Zöllner H, Liffers ST, Chromik AM, Uhl W, Szafranska-Schwarzbach AE, Tannapfel A, Hahn SA.

Int J Cancer. 2012 Jul 15;131(2):E86-95. doi: 10.1002/ijc.26466. Epub 2011 Nov 19.

20.

Hepatitis B virus status and risk of pancreatic ductal adenocarcinoma: a case-control study from China.

Ben Q, Li Z, Liu C, Cai Q, Yuan Y, Wang K, Xiao L, Gao J, Zhang H.

Pancreas. 2012 Apr;41(3):435-40. doi: 10.1097/MPA.0b013e31822ca176.

PMID:
22422136
Items per page

Supplemental Content

Write to the Help Desk